Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccess Intelligence Regulatory News (ACC)

Share Price Information for Access Intelligence (ACC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 57.00
Ask: 61.00
Change: 1.00 (1.72%)
Spread: 4.00 (7.018%)
Open: 58.00
High: 59.50
Low: 58.00
Prev. Close: 58.00
ACC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

18 Jun 2020 07:00

RNS Number : 2923Q
Access Intelligence PLC
18 June 2020
 

Access Intelligence plc

("Access Intelligence" or the "Company")

Trading Update

Access Intelligence (AIM: ACC), the technology innovator delivering Software-as-a-Service ("SaaS") solutions for the PR, communications and marketing industries, announces an update on trading for the six months ended 31 May 2020.

 

The Company's underlying business has performed well through the volatility seen in the first half of the year with strong renewal rates underpinning growth in Annual Contract Value ('ACV') of £1.04m in the period, over double the £0.45m increase for the equivalent period in 2019. This equates to organic annualised ACV growth of 12% and, importantly, all sub brands delivered double digit growth.

 

The Board anticipates total revenue to be £9.4m for the period, a year on year increase of over 50%. Excluding the acquisition of Pulsar, revenue grew by 10%. The Company also implemented a number of cost saving initiatives and the impact of these measures is expected to result in costs being reduced by approximately £1.1m this year. As a result of the comprehensive and rapid response taken by the Company to the COVID-19 disruption, its liquidity position remains strong with net cash of £2.6m at 31 May 2020 compared to £2.0m at 30 November 2019.

 

The Company reacted quickly to establish processes that enabled a successful transition to remote working that protected both the health and safety of staff but also prevented any disruption to client service or product development. The changes were made without impacting the longer-term growth prospects of the business, with cost saving measures including the Company furloughing approximately 15% of staff, salary and fee reductions for the Board and employees for three months, and the curtailment of discretionary spending.

 

Alongside the strong performance in renewal rates the period also saw new business success with clients added including global brands spanning the public, private and charity sectors. New clients wins included Aegon, Allen & Overy, Astra-Zeneca, Chanel, the Co-operative Group, Lotus, Ministry of Justice, Nintendo, OFGEM and the WWF. In the USA, Pulsar won new clients including Dow Jones, the International Monetary Fund, Levi Strauss and Twitter. The wins reflect the improved product portfolio which, since the addition of Pulsar in October 2019, has been strengthened to open up new sectors and international opportunities.

 

The Company continues to actively pursue new business opportunities and remains encouraged by its ongoing pipeline development. Nonetheless COVID-19 has inevitably affected the rate of new business wins as potential new customers put certain projects on hold and delayed investing in new technology products.

 

Given the dynamic nature of the situation it remains hard to predict how our pipeline of opportunities will evolve over the remainder of the year. The uncertainty means that whilst the resilience and strength that the business showed in the first half is very satisfactory and 93% of revenue is recurring, the Company's ability to generate new business in line with our original 2020 expectations remains unclear. Therefore, the Board considers it inappropriate to provide forward-looking guidance until the overall impact of COVID-19 becomes clearer.

 

Christopher Satterthwaite, Non-Executive Chairman of the Company, said: "Despite the challenge COVID-19 has presented all businesses, the last six months trading has demonstrated the strength of the Company with encouraging growth seen across the product portfolio. The strengthening of the portfolio with Pulsar will accelerate growth and by diversifying the product, sector and territorial opportunities, contribute to the Company's overall resilience."

 

 

Enquiries:

Access Intelligence plc

020 3426 4024

Joanna Arnold, CEO

Mark Fautley, CFO

finnCap Limited (Nominated Adviser and Broker)

020 7220 0500

Corporate Finance:

Marc Milmo/Kate Bannatyne/Matthew Radley

 

Corporate Broking:

Alice Lane/Sunila de Silva

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR"). Upon the publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFLFMWESSEEM
Date   Source Headline
7th Dec 20077:00 amRNSDirector/PDMR Shareholding
4th Dec 20077:01 amRNSTrading Statement
21st Nov 20077:00 amRNSDirector/PDMR Shareholding
9th Oct 20077:00 amRNSHolding(s) in Company
22nd Aug 200712:31 pmRNSDirector/PDMR Shareholding
16th Aug 20074:00 pmRNSWebsite Information
10th Aug 20077:00 amRNSDirector/PDMR Shareholding
9th Aug 20077:00 amRNSDirector/PDMR Shareholding
30th Jul 200712:02 pmRNSDirector/PDMR Shareholding
26th Jul 20077:01 amRNSInterim Results
10th Jul 20077:00 amRNSNotice of Results
18th Apr 20077:01 amRNSNew Contract Awarded
2nd Apr 20077:04 amRNSAccess Int targets NHS Trusts
15th Mar 20077:00 amPRNFinal Results
21st Feb 20077:01 amRNSNotice of Results
8th Jan 20077:00 amPRNTrading Statement
19th Dec 200611:39 amRNSVoting rights and capital
21st Nov 20067:01 amRNSDirector/PDMR Shareholding
2nd Nov 20061:11 pmRNSHolding(s) in Company
23rd Oct 20067:01 amRNSDirectors Share Purchases
16th Oct 200611:49 amRNSResult of EGM
20th Sep 20067:00 amPRN
1st Sep 20067:01 amRNSSenior Appointment
9th Aug 20063:41 pmRNSDirector/PDMR Shareholding
1st Aug 20067:02 amRNSInterim Results
25th Jul 20067:00 amRNSNotice of Interim Results
6th Jun 20061:41 pmRNSHolding(s) in Company
6th Jun 20061:40 pmRNSHolding(s) in Company
24th May 200612:33 pmRNSIssue of Equity
11th May 200611:28 amRNSIssue of Equity
10th May 20069:11 amRNSIssue of Equity - Amendment
8th May 20061:38 pmRNSIssue of Equity
9th Mar 20067:01 amRNSDirector/PDMR Shareholding
8th Mar 20067:00 amPRNFinal Results
13th Feb 20067:00 amRNSNotice of Results
2nd Dec 20057:00 amRNSTrading Statement
6th Oct 20056:17 pmRNSDirector/PDMR Shareholding
6th Jul 20057:00 amRNSInterim Results
6th Jul 20057:00 amRNSAcquisition
27th Jun 20054:26 pmRNSResult of EGM
27th Jun 20057:00 amRNSNotice of Results
14th Jun 20057:00 amRNSAGM Statement
2nd Jun 20055:46 pmRNSSch 1 - Access Intelligence
2nd Jun 20057:00 amRNSAcquisition
20th May 20057:00 amRNSABTA Partnership
15th Apr 20057:00 amRNSTrading Update
24th Feb 20057:01 amRNSFinal Results
7th Feb 20059:50 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.